Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
about
Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirusMyeloid suppressor cells and immune modulation in lung cancerKaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cellsExpression variation: its relevance to emergence of chronic disease and to therapyCyclooxygenase-2 and the inflammogenesis of breast cancer.Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects.Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis.Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitorsDissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathwayRestoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaEpigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesisIbuprofen and fatal lung cancer: A brief report of the prospective results from the Third National Health and Nutrition Examination Survey (NHANES III).Alterations of gene expression and protein synthesis in co-cultured adipose tissue-derived stem cells and squamous cell-carcinoma cells: consequences for clinical applications.Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motifConvergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.Coordinated increased expression of Cyclooxygenase2 and nuclear factor κB is a steady feature of urinary bladder carcinogenesisAdenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cellsOverexpression of COX-2 in celecoxib-resistant breast cancer cell lines.Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer riskOncolytic herpes simplex virus 1 encoding 15-prostaglandin dehydrogenase mitigates immune suppression and reduces ectopic primary and metastatic breast cancer in mice.Colorectal cancer drug target prediction using ontology-based inference and network analysis.Distribution of cyclooxygenases 1 and 2 in the uterus and breast of cynomolgus monkeys-effects of hormone treatment.Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancerTLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer.Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.Chemoprevention of arylamine-induced colorectal aberrant crypts.Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde.Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model.Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats.Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.Spatiotemporal assessments of dermal hyperemia enable accurate prediction of experimental cutaneous carcinogenesis as well as chemopreventive activity.Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.Myeloid derived suppressor cells: Targets for therapy.Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.Activation of apoptosis by 1-hydroxy-5,7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos.
P2860
Q24651563-D4B132DB-EF6B-41FA-9FE1-D99D072BA7CAQ26823251-A34177B4-7479-4315-8537-EBAC846F01C9Q28221605-6C7592FF-C560-4578-A9D0-2461E6891576Q28475609-AE2A02DC-12EA-4462-A685-1CFA77097CBDQ30367680-DFF59419-CC6B-4A1F-B035-09A6EEAE87D6Q30394633-30D9802F-6833-475E-AC61-FE98D3FA0E57Q30841754-B6B6C7B5-4EBE-46C6-80A5-EC4B41BF6202Q33360108-89FEAA24-C4B6-42D9-A8F4-4A56FAEFE540Q33495581-7BF813E2-0CD8-44B7-B540-27B80E940F62Q33554975-E7471FC0-9755-4581-9332-3CBFDF0B3884Q33646333-33BC68B7-6EED-44C2-BF56-7122493B261BQ33739319-24DFDC48-C8E1-42E2-9BD6-1F562824B77AQ33748296-3ED86A0B-F622-43A2-8D3A-CB5D2A8275B1Q33827061-6F7F896C-D670-4942-A57A-33779D738253Q33846983-546F964C-2AF0-4AE7-8E30-1CF28146F875Q33954537-C2A3E50C-5587-406F-9C5B-D20C188B3E86Q34026054-2EA8ADC4-52E5-4881-88FD-4045CCD71B96Q34106055-95BFA3C7-6B7A-4C73-82FA-2B7099DE917AQ34107172-A3BB81EA-6FF7-4223-A6B4-91AB5BB1A979Q34143022-ABB927E0-2BDD-4A76-97E2-789399D6FF11Q34320362-783A282E-2140-4650-84FB-E1CA29F3D7D7Q34342182-E6127B47-DC50-4211-BBB5-F442D0C7662BQ34591055-6A4633ED-D57E-40B5-9B2A-131603E640AFQ34794017-0F63090A-658E-47E6-8975-6186CFF449B6Q35077655-764C348F-416D-4E64-B252-C0C9BB0021C2Q35221224-7C026550-A1CA-48B7-96D7-80F19682D5B1Q35227349-02CC02B4-12C6-41C6-8E97-0C18E4D264A0Q35881186-DD9D8358-2C92-4D55-B3C2-91AD704209CFQ35939623-5097A3B5-FE3C-4364-91EA-A22186B482C7Q36232504-C5D38659-AF04-46B1-B6EA-8ABA9C077BE1Q36298166-5B8E993B-D7F9-41E4-8605-8EC7EB8B904CQ36451713-415A84EF-6270-4EA2-953C-DF52E5F6CA53Q36482330-A79AE73A-0586-42DB-A146-AD46FFDD8DECQ36492613-F63D6F7D-5ED5-4D2A-B9D7-44912DF83939Q36505700-50D267A9-9176-4A1C-B55F-A6C68F768381Q36510962-C1A6E5E7-823F-4FC9-A42F-6EA818AE833DQ36717145-D0607D7B-F745-44B9-A6D5-D0E2B04D9677Q36845851-A7FAA4A0-ED5C-4D97-8BCA-865DD97E48C3Q37205669-F4C4F98D-8957-4CBF-AC62-60BFD54F704DQ37216528-CC15E033-8635-4E16-B8EB-B5D8817F2690
P2860
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@ast
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@en
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@nl
type
label
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@ast
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@en
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@nl
prefLabel
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@ast
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@en
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@nl
P356
P1476
Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
@en
P2093
Randall E Harris
P304
P356
10.1007/1-4020-5688-5_4
P407
P577
2007-01-01T00:00:00Z